Cellectar Biosciences, Inc.
CLRBNasdaqCIK 1279704HealthcareFiscal year ends Dec 31
Reports and events: 530 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1307:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-095460 |
| 2026-08-1307:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-095426 |
| 2026-07-1017:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-082719 |
| 2026-05-2908:50 ET | S-1/A | Registration statement, amended | 0001104659-26-067933 |
| 2026-05-2817:13 ET | DEF 14A | Proxy statementPeriod 2026-07-07 | 0001104659-26-067626 |
| 2026-05-1917:05 ET | S-1 | Registration statement | 0001104659-26-063918 |
| 2026-05-1816:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-063202 |
| 2026-05-1407:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-060693 |
| 2026-05-1407:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-060678 |
| 2026-05-0806:04 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-057460 |
| 2026-04-3016:51 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001104659-26-053090 |
| 2026-03-0407:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-023169 |
| 2026-03-0407:21 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-023167 |
| 2025-11-1307:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-110848 |
| 2025-11-1307:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-110827 |
| 2025-10-2016:31 ET | S-1 | Registration statement | 0001104659-25-100854 |
| 2025-10-1016:30 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-098725 |
| 2025-10-0607:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-096928 |
| 2025-08-1407:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-078102 |
| 2025-08-1407:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001410578-25-001778 |
| 2025-06-3008:29 ET | S-1/A | Registration statement, amended | 0001104659-25-063849 |
| 2025-06-2609:26 ET | 8-K | 8.01 Other events | 0001104659-25-062837 |
| 2025-06-2609:22 ET | S-1 | Registration statement | 0001104659-25-062834 |
| 2025-06-2517:22 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-062639 |
| 2025-06-1816:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-060661 |
| 2025-06-1316:30 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-059400 |
| 2025-06-0509:26 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-056697 |
| 2025-05-1307:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-047568 |
| 2025-05-1307:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001410578-25-001205 |
| 2025-05-0106:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-042870 |
| 2025-04-2816:31 ET | DEF 14A | Proxy statementPeriod 2025-06-13 | 0001104659-25-040241 |
| 2025-03-1716:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-024446 |
| 2025-03-1307:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-023216 |
| 2025-03-1306:50 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001410578-25-000329 |
| 2025-01-3116:30 ET | 8-K | 3.01 Delisting notice | 0001104659-25-008127 |
| 2025-01-2916:16 ET | S-1 | Registration statement | 0001410578-25-000060 |
| 2025-01-1406:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-003208 |
| 2024-12-1109:05 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-127487 |
| 2024-11-1807:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-119941 |
| 2024-11-1806:46 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001410578-24-002012 |
| 2024-11-1516:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-119738 |
| 2024-11-0117:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-113549 |
| 2024-10-2917:09 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001410578-24-001708 |
| 2024-10-2917:03 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-03-31 | 0001410578-24-001706 |
| 2024-10-2916:56 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001410578-24-001704 |
| 2024-08-2317:15 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-092495 |
| 2024-08-1306:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-088606 |
| 2024-08-0917:00 ET | 8-K | 4.02 Non-reliance on financial statements | 0001104659-24-087859 |
| 2024-07-2306:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-081680 |
| 2024-07-2206:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-081307 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.